Editor's Note Effective waste segregation and adopting a circular economy approach can significantly reduce environmental impact of incinerating hospital waste incorrectly classified as hazardous, according to a narrative review published August 19 in the Medical Journal of Australia. However, surgeons' concerns about patient safety and insufficient systemic policies can hinder…

Read More

Editor's Note Combining dexterity and cost-effectiveness, handheld robotic devices offer potential to bridge the gap between traditional laparoscopy and more expensive robotic platforms, researchers concluded August 8 in the journal Surgery. The mini-review of clinical trials covered clinical applications of three handheld robotic devices: the HandX powered laparoscopic instrument from…

Read More

Editor's Note A shuttered bariatric surgery center in Oklahoma last month is just one example of how the rise of Glucagon-like peptide-1 (GLP-1) agonists are reshaping health systems’ investments, Axios reported August 13. Rather than “massive hospital towers with cardiology clinics, dialysis beds and joint replacement centers,” the focus is…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop  compressions in adults whose hearts suddenly stop, according to the…

Read More

Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events.   These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…

Read More

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

Editor's Note Evidence is mounting for the use of antibiotics as a valid alternative to surgery for acute appendicitis, including in pediatric cases, the Washington Post reported August 17. The article details how this treatment—described as a “dark secret” by one expert testifying to its use in the 1950s, prior…

Read More

Editor's Note The US Food and Drug Adminstration (FDA) has classified a recall of ICU Medical’s Plum 360, Plum A+ and Plum A+3 infusion pumps as Class 1, the most severe category indicating risk of serious injury or death. According to he agency’s August 20 announcement, the company is updating…

Read More

Editor's Note A newly developed biomaterial could treat crippling arthritis by prompting the growth of new cartilage, according to an animal study conducted at Northwestern University and published in the Proceedings of the National Academy of Sciences. According to an August 6 article by U.S. News and World Report, the…

Read More

Editor's Note An August 6 report in MedPage Today details how the Physicians Committee for Responsible Medicine (PCRM) is pushing to end the practice of using live animals for physiology training. According to the article, some surgical residencies use live animals (usually pigs) as practice patients. In contrast, only 3%…

Read More